Nuveen’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-270,087
Closed -$2.13M 3289
2025
Q1
$2.13M Buy
270,087
+204,284
+310% +$696K ﹤0.01% 2314
2024
Q4
$255K Hold
65,803
﹤0.01% 3163
2024
Q3
$665K Hold
65,803
﹤0.01% 2918
2024
Q2
$296K Buy
65,803
+10,619
+19% +$108K ﹤0.01% 3154
2024
Q1
$825K Hold
55,184
﹤0.01% 2778
2023
Q4
$801K Buy
55,184
+10,397
+23% +$126K ﹤0.01% 2822
2023
Q3
$616K Sell
44,787
-10,288
-19% -$186K ﹤0.01% 2773
2023
Q2
$1.21M Buy
+55,075
New +$1.72M ﹤0.01% 2572
2022
Q2
Sell
-39,622
Closed -$219K 3262
2022
Q1
$219K Hold
39,622
﹤0.01% 3173
2021
Q4
$316K Buy
39,622
+19,355
+96% +$205K ﹤0.01% 3165
2021
Q3
$223K Buy
20,267
+6,579
+48% +$83.7K ﹤0.01% 3274
2021
Q2
$214K Buy
+13,688
New +$242K ﹤0.01% 3243

Other funds holding BMEA

Nuveen's BMEA Position: Q2 2025 in Review

Nuveen sold out of Biomea Fusion (BMEA) in Q2 2025, closing a stake of 270,087 shares — an estimated $2.13M sold.

Nuveen first reported a position in BMEA in Q2 2021 and held it in 12 quarters. The position peaked at $2.13M in Q1 2025. 87 funds tracked by Wall St. Rank hold BMEA as of Q2 2025.

  • Nuveen reported no remaining Biomea Fusion position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 270,087 Biomea Fusion shares in Q2 2025, an estimated $2.13M.
  • Nuveen first reported a position in Biomea Fusion in Q2 2021 and held it in 12 quarters.
  • Nuveen's Biomea Fusion position peaked at $2.13M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.